Update on Slump Sale of Empty Hard Gelatin Capsule Business

Core Business DivestedStrategic Transactions View source PDF

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.3%1-day move

₹12.61

prior close

₹12.59

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.0+0.2+0.7-1.3-3.4-3.8-2.3+7.5+8.2-3.8-1.0-7.5—

Up moveDown movePending

AI summary

Nectar Lifesciences has updated the exchange on its slump sale of the Empty Hard Gelatin Capsule business to Capnest Health Care Private Limited. The company and purchaser have mutually agreed to extend the expected completion date to on or before July 31, 2026. Other terms disclosed earlier in the December 20, 2025 filing remain unchanged.

Likely market impact

Slight delay in divestment completion timeline; deal still on track, no change in other terms. Minor near-term overhang for shareholders.